104 related articles for article (PubMed ID: 8383865)
1. Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors.
Kvols LK; Brown ML; O'Connor MK; Hung JC; Hayostek RJ; Reubi JC; Lamberts SW
Radiology; 1993 Apr; 187(1):129-33. PubMed ID: 8383865
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin-receptor imaging in the localization of endocrine tumors.
Lamberts SW; Bakker WH; Reubi JC; Krenning EP
N Engl J Med; 1990 Nov; 323(18):1246-9. PubMed ID: 2170840
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
[TBL] [Abstract][Full Text] [Related]
4. Scintiscans and carcinoid tumors.
Carnaille B; Nocaudie M; Pattou F; Huglo D; Deveaux M; Marchandise X; Proye C
Surgery; 1994 Dec; 116(6):1118-21; discussion 1121-2. PubMed ID: 7985096
[TBL] [Abstract][Full Text] [Related]
5. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
[TBL] [Abstract][Full Text] [Related]
6. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
Bomanji J; Mather S; Moyes J; Ellison D; Grossman A; Britton KE; Besser GM
J Nucl Med; 1992 Jun; 33(6):1121-4. PubMed ID: 1597726
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin-receptor imaging for the detection of tumors.
Patel YC
N Engl J Med; 1990 Nov; 323(18):1274-6. PubMed ID: 2170841
[No Abstract] [Full Text] [Related]
8. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
Lobrano MB; McCarthy K; Adams L; Neitzschman H
Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
[TBL] [Abstract][Full Text] [Related]
9. The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide.
Kvols LK; Reubi JC; Horisberger U; Moertel CG; Rubin J; Charboneau JW
Yale J Biol Med; 1992; 65(5):505-18; discussion 531-6. PubMed ID: 1364090
[TBL] [Abstract][Full Text] [Related]
10. Octreotide scintigraphy localizes somatostatin receptor-positive islet cell carcinomas.
Becker W; Marienhagen J; Scheubel R; Saptogino A; Bakker WH; Breeman WA; Wolf F
Eur J Nucl Med; 1991; 18(11):924-7. PubMed ID: 1684323
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor localization of pancreatic endocrine tumors.
Corleto VD; Scopinaro F; Angeletti S; Materia A; Basso N; Polettini E; Annibale B; Schillaci O; D'Ambra G; Marignani M; Gualdi G; Bordi C; Passaro EJ; Delle Fave G
World J Surg; 1996 Feb; 20(2):241-4. PubMed ID: 8661825
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative gamma detection reveals abdominal endocrine tumors more efficiently than somatostatin receptor scintigraphy.
Ohrvall U; Westlin JE; Nilsson S; Juhlin C; Rastad J; Lundqvist H; Akerström G
Cancer; 1997 Dec; 80(12 Suppl):2490-4. PubMed ID: 9406700
[TBL] [Abstract][Full Text] [Related]
13. Use of isotope-labeled somatostatin analogs for visualization of islet cell tumors.
van Eyck CH; Bruining HA; Reubi JC; Bakker WH; Oei HY; Krenning EP; Lamberts SW
World J Surg; 1993; 17(4):444-7. PubMed ID: 8395748
[TBL] [Abstract][Full Text] [Related]
14. Localization of metastatic gastroenteropancreatic tumours by somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-octreotide.
Hammond PJ; Arka A; Peters AM; Bloom SR; Gilbey SG
Q J Med; 1994 Feb; 87(2):83-8. PubMed ID: 8153292
[TBL] [Abstract][Full Text] [Related]
15. Iodine-123-Tyr-3-octreotide uptake in pancreatic endocrine tumors and in carcinoids in relation to hormonal inhibition by octreotide.
Nocaudie-Calzada M; Huglo D; Deveaux M; Carnaille B; Proye C; Marchandise X
J Nucl Med; 1994 Jan; 35(1):57-62. PubMed ID: 8271061
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative localization of gut endocrine tumors with radiolabeled somatostatin analogs and a gamma-detecting probe.
Benevento A; Dominioni L; Carcano G; Dionigi R
Semin Surg Oncol; 1998 Dec; 15(4):239-44. PubMed ID: 9829380
[TBL] [Abstract][Full Text] [Related]
17. Experience with somatostatin receptor scintigraphy in the management of pulmonary carcinoid tumors.
Yellin A; Zwas ST; Rozenman J; Simansky DA; Goshen E
Isr Med Assoc J; 2005 Nov; 7(11):712-6. PubMed ID: 16308994
[TBL] [Abstract][Full Text] [Related]
18. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
[TBL] [Abstract][Full Text] [Related]
19. In vivo somatostatin receptor imaging in the detection and treatment of gastrointestinal cancer.
Schubert ML
Gastroenterology; 1991 Apr; 100(4):1143-4. PubMed ID: 1848196
[No Abstract] [Full Text] [Related]
20. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors.
Virgolini I; Raderer M; Kurtaran A; Angelberger P; Banyai S; Yang Q; Li S; Banyai M; Pidlich J; Niederle B; Scheithauer W; Valent P
N Engl J Med; 1994 Oct; 331(17):1116-21. PubMed ID: 7935635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
